AstraZeneca PLC ADR (AZN) Social Stream
ASTRAZENECA PLC (AZN) Price Targets From Analysts
Use the tables below to see what analysts covering ASTRAZENECA PLC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-15 | 7 | $73 | $66 | $69.1 | $67.34 | 2.61% |
2021-12-07 | 7 | $73 | $66 | $69.1 | $67.34 | 2.61% |
2022-01-17 | 7 | $73 | $60 | $67.1 | $67.34 | -0.36% |
2022-02-02 | 7 | $73 | $62.5 | $67.725 | $67.34 | 0.57% |
2022-02-10 | 7 | $69.4 | $62.5 | $65.725 | $67.34 | -2.4% |
2022-02-23 | 7 | $69.4 | $59.5 | $64.975 | $67.34 | -3.51% |
2022-02-24 | 7 | $70 | $59.5 | $66.225 | $67.34 | -1.66% |
2022-04-06 | 6 | $70 | $59.5 | $66.225 | $67.34 | -1.66% |
2022-04-11 | 6 | $82 | $59.5 | $69.375 | $67.34 | 3.02% |
2022-04-28 | 5 | $80 | $62 | $70.35 | $67.34 | 4.47% |
2022-04-30 | 5 | $82 | $62 | $73.5 | $67.34 | 9.15% |
2022-05-03 | 5 | $80 | $62 | $73 | $67.34 | 8.41% |
2022-06-06 | 5 | $80 | $59 | $73.5 | $67.34 | 9.15% |
2022-08-13 | 6 | $80 | $58.5 | $73.375 | $67.34 | 8.96% |
2022-10-05 | 7 | $80 | $58.5 | $73.7 | $67.34 | 9.44% |
2022-10-28 | 7 | $80 | $54.5 | $72.9 | $67.34 | 8.26% |
2022-11-11 | 7 | $80 | $54.5 | $73.5 | $67.34 | 9.15% |
2022-12-03 | 7 | $80 | $54.5 | $73.7 | $67.34 | 9.44% |
2022-12-12 | 7 | $88 | $54.5 | $75.3 | $67.34 | 11.82% |
2023-01-04 | 8 | $88 | $64.5 | $77.3 | $67.34 | 14.79% |
2023-04-18 | 9 | $88 | $64.5 | $78.083 | $67.34 | 15.95% |
2023-04-27 | 9 | $88 | $67 | $78.5 | $67.34 | 16.57% |
2023-06-07 | 9 | $88 | $67 | $78.166 | $67.34 | 16.08% |
2023-06-15 | 9 | $88 | $67 | $79.166 | $67.34 | 17.56% |
2023-07-07 | 9 | $88 | $66.5 | $79.083 | $67.34 | 17.44% |
2023-08-01 | 10 | $88 | $66.5 | $79.416 | $67.34 | 17.93% |
2023-09-11 | 10 | $88 | $66.5 | $80.3 | $67.34 | 19.25% |
The Trend in the Analyst Price Target
Over the past 14 months, AZN's average price target has gone up $6.92.
Over the past 52 weeks, AZN's average upside potential has been 14.3%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-10-05 | 7 | 80 | 58.5 | 73.700 | 56.73 | 29.91% |
2022-10-12 | 7 | 80 | 54.5 | 72.900 | 55.07 | 32.38% |
2022-11-11 | 7 | 80 | 54.5 | 73.500 | 62.77 | 17.09% |
2022-12-14 | 7 | 88 | 64.5 | 77.300 | 70.44 | 9.74% |
2023-05-01 | 9 | 88 | 67.0 | 78.166 | 73.50 | 6.35% |
AZN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.45 | 7 | 1 | 2 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 30 weeks, AZN's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ASTRAZENECA PLC's number of analysts covering the stock is greater than 144.18% of stocks in the mega market cap category.
- In terms of how ASTRAZENECA PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -379.29% of that group.
- In the context of Pharmaceutical Products stocks, ASTRAZENECA PLC's upside potential (average analyst target price relative to current price) is greater than 497.74% of them.
- In the context of Pharmaceutical Products stocks, ASTRAZENECA PLC's average analyst price target is greater than 2717.48% of them.
In the Pharmaceutical Products industry, NVS, ABBV, and MRK are the three stocks most similar to ASTRAZENECA PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is AZN a Buy, Hold or Sell? See the POWR Ratings now!